Retinal Neuroprotective Effects of Flibanserin, an FDA-Approved Dual Serotonin Receptor Agonist-Antagonist.

Autor: Coyner, Aaron S.1, Ryals, Renee C.1, Ku, Cristy A.1, Fischer, Cody M.1, Patel, Rachel C.1, Datta, Shreya1, Yang, Paul1, Wen, Yuquan2, Hen, René3, Pennesi, Mark E.1 pennesim@ohsu.edu
Zdroj: PLoS ONE. 7/22/2016, Vol. 11 Issue 7, p1-18. 18p.
Databáze: Academic Search Ultimate